Impf-Info - der blog

Font size: +

Paxlovid - Nutzen nur für Ü65 OHNE vorherige Immunität? Da dürften dann zwei Handvoll Dosen reichen als Vorrat...

...

Oral Nirmatrelvir and Severe Covid-19 Outcomes During the Omicron Surge | Research Square

Background Nirmatrelvir, an inhibitor of the main protease of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has demonstrated a significant decrease in the risk of progression to severe disease in symptomatic high-risk patients infected with the B.1.617.2 (delta) varian...
BioNTech und sein Omikron-Impfstoff - gut, dass Im...
Myokarditis-Risiko nach Covid nicht erhöht - ganz ...

By accepting you will be accessing a service provided by a third-party external to https://www.impf-info.de/